Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.39
-0.16 (-0.91%)
At close: May 1, 2026, 4:00 PM EDT
17.55
+0.16 (0.92%)
After-hours: May 1, 2026, 4:20 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.87 billion as of May 1, 2026. Its market cap has increased by 222.92% in one year.
Market Cap
2.87B
Enterprise Value
1.93B
1-Year Change
222.92%
Ranking
Category
Stock Price
$17.39
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.87B, an increase of 263.28%. That is a compound annual growth rate of 25.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 2.87B | -10.79% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oruka Therapeutics | 3.14B |
| Erasca | 3.12B |
| Beam Therapeutics | 3.08B |
| Tango Therapeutics | 3.03B |
| Structure Therapeutics | 3.00B |
| Arcutis Biotherapeutics | 2.92B |
| Nektar Therapeutics | 2.92B |
| Denali Therapeutics | 2.90B |